Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing’s and other Small Round Cell Sarcomas

BACKGROUND: To evaluate tolerability and maintenance of dose intensity of 2 weekly treatment with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide (VDC/IE) in patients with advanced small round cell sarcomas including Ewing family tumours (EFT), desmoplastic small ro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Whelan, Jeremy, Khan, Atia, Sharma, Anand, Rothermundt, Christian, Dileo, Palma, Michelagnoli, Maria, Seddon, Beatrice, Strausss, Sandra
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2012
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3571911/
https://ncbi.nlm.nih.gov/pubmed/22998944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-3329-2-12
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares